FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology. Disclosed is a multi-agent structure inducing an immune response against a cancer cell in a mammal, as well as a vector, a composition, a pharmaceutical composition and a method of treating cancer.
EFFECT: invention can be used in medicine to increase the immune response to cancer.
51 cl, 20 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETERODIMERIC FC-FUSED PROTEINS IL15/IL15Rα | 2017 |
|
RU2779938C2 |
| IL-12 HETERODIMERIC FC FUSION PROTEINS | 2019 |
|
RU2819097C2 |
| CHIMERIC ANTIGEN RECEPTORS TARGETING CD70 | 2019 |
|
RU2801824C2 |
| CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) FOR CANCER TREATMENT | 2019 |
|
RU2811466C2 |
| IMMUNOCYTOKINES AND THEIR USE | 2021 |
|
RU2818371C1 |
| METHODS FOR IMPROVEMENT OF MONOCOTYLEDON PLANTS | 2015 |
|
RU2727428C2 |
| ANTI-CD39 ANTIBODIES, COMPOSITIONS CONTAINING ANTI-CD39 ANTIBODIES AND METHODS OF APPLICATION OF ANTI-CD39 ANTIBODIES | 2018 |
|
RU2795348C2 |
| METHODS OF PLANTS IMPROVEMENT | 2015 |
|
RU2727424C2 |
| ANTIBODIES SPECIFIC FOR CD70 AND THEIR USE | 2019 |
|
RU2801093C2 |
| MOLECULES TARGETING A TYPE III SECRETION SYSTEM | 2016 |
|
RU2759949C2 |
